Print Page | E-mail Page | RSS Feeds | E-mail Alerts | |
![]() | Webcast Q2 2010 CareFusion Earnings Conference Call (Live) 02/09/10 at 5:00 p.m. ET |
| ||||||||||||
CareFusion is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. We develop market-leading technologies including Alaris® IV pumps, Pyxis® automated dispensing and patient identification systems, AVEA® and Pulmonetic Systems ventilation and respiratory products, ChloraPrep® and MedMined™ services for infection prevention, neurological monitoring and diagnostic products, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine.
Headquartered in San Diego, CA, we employ more than 15,000 people in more than 20 countries worldwide.
| Calendar of Events |
| ||||||
| Recent News |
| CareFusion Announces Completion of Exchange Offer for 4.125% Senior Notes Due 2012, 5.125% Senior Notes Due 2014, and 6.375% Senior Notes Due 2019 - 02/05/10 |
| SAN DIEGO, Feb 05, 2010 /PRNewswire via COMTEX/ -- CareFusion Corporation (NYSE: CFN) announced today that it has completed its previously announced offer to exchange (the "Exchange Offer") any and all of its outstanding $250 million aggregate princ... More >> |
| CareFusion Announces 5-Year, Sole Source Pyxis(R) Perioperative Solutions Agreement With CHRISTUS Health - 02/01/10 |
| SAN DIEGO, Feb 01, 2010 /PRNewswire via COMTEX/ -- CareFusion (NYSE: CFN), a leading, global medical device company, announced today that it has entered into a 5-year sole source agreement with Dallas-based CHRISTUS Health, one of the top ten Cathol... More >> |
| CareFusion, George Wein Announce Details of New York Jazz Festival, Dates for Newport Festival - 01/27/10 |
| NEW YORK, Jan 27, 2010 /PRNewswire via COMTEX/ -- On the heels of a well-received 2009 jazz festival series, CareFusion, a leading global medical device company, and Jazz Impresario George Wein, announced today details about the CareFusion Jazz Fest... More >> |
| CareFusion Signs Exclusive Partnership Agreement With Minimally Invasive Devices to Distribute FloShield Laparoscopic Technology - 01/26/10 |
| SAN DIEGO, Jan 26, 2010 /PRNewswire via COMTEX/ -- CareFusion (NYSE: CFN), a leading, global medical device company, today announced a distribution agreement with Minimally Invasive Devices, Inc., a venture-backed Ohio medical device company, to sel... More >> |
| CareFusion to Donate $3.1 Million in Products for Ongoing Earthquake Relief Efforts in Haiti - 01/21/10 |
| SAN DIEGO, Jan 21, 2010 /PRNewswire via COMTEX/ -- CareFusion (NYSE: CFN), a leading, global medical device company, today announced it will donate 100 CareFusion ventilators and 200 infusion pumps to aid in the ongoing humanitarian efforts in Haiti.... More >> |
| CareFusion Will Host an Earnings Conference Call on Feb. 9 to Discuss the Results for the Second Quarter of Fiscal 2010 - 01/11/10 |
| SAN DIEGO, Jan 11, 2010 /PRNewswire via COMTEX/ -- CareFusion Corporation (NYSE: CFN) today announced plans to release second-quarter results for its fiscal 2010 on Tuesday, Feb. 9 following the close of trading on the New York Stock Exchange. The ... More >> |
| FDA Lifts Injunction on Manufacture and Sale of CareFusion Alaris(R) SE Pump - 01/11/10 |
| SAN DIEGO, Jan 11, 2010 /PRNewswire via COMTEX/ -- CareFusion (NYSE: CFN), a leading, global medical device company, announced today that the Food and Drug Administration (FDA) has given the company permission to resume manufacturing and marketing t... More >> |
| New Study Published in The New England Journal of Medicine Shows Superiority of CareFusion ChloraPrep(R) Compared to Povidone-Iodine as a Surgical Skin Prep - 01/07/10 |
| Prospective, Randomized Trial Shows Significantly Better Patient Outcomes in Selected Surgical Procedures within 30 Days When ChloraPrep is Used Preoperatively, Compared to Povidone-iodineSAN DIEGO, Jan 07, 2010 /PRNewswire via COMTEX/ -- Data publi... More >> |
| CareFusion Announces Exchange Offer for 4.125% Senior Notes Due 2012, 5.125% Senior Notes Due 2014, and 6.375% Senior Notes Due 2019 - 01/06/10 |
| SAN DIEGO, Jan 06, 2010 /PRNewswire via COMTEX/ -- CareFusion Corporation (NYSE: CFN) announced today that it has commenced an offer to exchange any and all of its outstanding $250 million aggregate principal amount of 4.125% Senior Notes due 2012, ... More >> |
| CareFusion Recommends Rejection of Mini-Tender Offer by TRC Capital - 12/17/09 |
| SAN DIEGO, Dec 17, 2009 /PRNewswire-FirstCall via COMTEX/ -- CareFusion Corporation (NYSE: CFN) announced today that it has been notified of an unsolicited mini-tender offer by TRC Capital Corporation (TRC) to purchase up to four million shares of Ca... More >> |
Cautions Concerning Forward-Looking Statements: This website contains forward-looking statements addressing the planned spinoff of Cardinal Health’s clinical and medical products businesses as a separate company named CareFusion Corporation, which is dependent upon future events or developments. These matters are subject to risks and uncertainties that could cause actual events (including the planned spinoff) and results to differ materially from those projected, anticipated or implied. These risks and uncertainties include uncertainties regarding the planned spinoff of CareFusion, including the timing and terms of any such spinoff and whether such spinoff will be completed as it is subject to a number of conditions. In addition, Cardinal Health and CareFusion are subject to additional risks and uncertainties described in CareFusion’s Form 10, as amended, and Cardinal Health’s Form 10-K, Form 10-Q and Form 8-K reports (including all amendments to those reports) and exhibits to those reports. Except to the extent required by applicable law, Cardinal Health and CareFusion undertake no obligation to update or revise any forward-looking statement.





